Anti-Cav1.2a (Alpha1c subunit of Voltage-Gated Calcium Channel, Cardiac L-Type)

Anti-Cav1.2a (Alpha1c subunit of Voltage-Gated Calcium Channel, Cardiac L-Type)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
C2097-85B4.100 100 µg - -

3 - 19 Werktage*

659,00 €
 
Ion channels are integral membrane proteins that help establish and control the small voltage... mehr
Produktinformationen "Anti-Cav1.2a (Alpha1c subunit of Voltage-Gated Calcium Channel, Cardiac L-Type)"
Ion channels are integral membrane proteins that help establish and control the small voltage gradient across the plasma membrane of living cells by allowing the flow of ions down their electrochemical gradient. Where some ion channels permit the passage of ions based on charge, others conduct based on an ionic species, such as sodium or potassium. Furthermore, in some ion channels, the passage is governed by a gate which is controlled by chemical or electrical signals, temperature or mechanical forces. There are a few main classifications of gated ion channels. The first are voltage-gated ion channels which open and close in response to membrane potential. These are then separated into sodium, calcium, potassium, proton, transient receptor and cyclic nucleotide-gated channels. Ligand-gated ion channels open in response to specific ligand molecules binding to the extracellular domain of the receptor protein. The other gated classifications include activation and inactivation by second messengers, inward-rectifier potassium channels, calcium-activated potassium channels, two-pore-domain potassium channels, light-gated channels, mechano-sensitive ion channels and cyclic nucleotide-gated channels. Finally, the other classifications are based on less normal characteristics such as two-pore channels, and transient receptor potential channels. Specifially, Cav1.2 is a cardiac L-type calcium channel, and is important for excitation and contraction of the heart. It may be associated with a variant of Long QT syndrome called Timothy's syndrome and also with Brugada syndrome. Some references also suggest it is related to bipolar disease as well. Applications: Suitable for use in Western Blot, Immunoprecipitation, Immunofluorescence/Immunocytochemistry and Immunohistochemistry. Other applications not tested. Recommended Dilutions: Western Blot: 1:1000, Immunohistochemistry: 1:1000, Immunofluorescence (IC): 1:1000, Optimal dilutions to be determined by the researcher, ., Storage and Stability:, May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Schlagworte: Anti-CACH2, Anti-CACB-receptor, Anti-Smooth muscle calcium channel blocker receptor, Anti-Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle
Hersteller: United States Biological
Hersteller-Nr: C2097-85B4

Eigenschaften

Anwendung: ICC, IF, IHC, IP, WB
Antikörper-Typ: Monoclonal
Klon: 10F687
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: hamster, human, mouse, rat
Immunogen: Fusion protein aa 1507-1733 (intracellular carboxyl terminus) of rabbit Cav1.2 (accession number P15381).
Format: Affinity Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Cav1.2a (Alpha1c subunit of Voltage-Gated Calcium Channel, Cardiac L-Type)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen